Readi-cat 2 Berry Smoothie
(Barium Sulfate)Check Drug InteractionsCheck known drug interactions.
Check Drug InteractionsReadi-Cat 2 Berry Smoothie Prescribing Information
Warning and Precautions (READI-CAT 2 contains sorbitol which may cause severe reactions if ingested by patients with hereditary fructose intolerance, such as: vomiting, hypoglycemia, jaundice, hemorrhage, hepatomegaly, hyperuricemia, and kidney failure. Before administration of READI-CAT 2 assess patients for a history of hereditary fructose intolerance and avoid use in these patients. | 2/2017 |
READI-CAT 2 and READI-CAT 2 SMOOTHIES are indicated
for use in computed tomography (CT) of the abdomen to delineate the
gastrointestinal (GI) tract in adult and pediatric patients.
For oral use only:
- Adults and pediatric patients 12 years and older: 450 mL
to 900 mL (9 g to 18 g of barium sulfate, respectively) ()2.1 Recommended DosageBase dosing on individual needs and procedure
to be performed.- Adult and pediatric patients 12 years and older: 450 mL
to 900 mL (9 g to 18 g of barium sulfate) - Patients younger than 12 years of age: adjust dose based
on relative GI volume
- Adult and pediatric patients 12 years and older: 450 mL
- Patients younger than 12 years of age: scale down dose based
on relative GI volume ()2.1 Recommended DosageBase dosing on individual needs and procedure
to be performed.- Adult and pediatric patients 12 years and older: 450 mL
to 900 mL (9 g to 18 g of barium sulfate) - Patients younger than 12 years of age: adjust dose based
on relative GI volume
- Adult and pediatric patients 12 years and older: 450 mL
Oral suspension: 9 grams of barium
sulfate supplied as a suspension (2% w/v) in a single-dose HDPE plastic
bottle.
Risk Summary
READI-CAT
2 products are not absorbed systemically following oral administration,
and maternal use is not expected to result in fetal exposure to the
drug.
READI-CAT 2 products are contraindicated
in patients:
- with known or suspected perforation of the GI tract
- with known obstruction of the GI tract
- at high risk of GI perforation such as those with a recent
prior GI perforation, acute GI hemorrhage or ischemia, toxic megacolon,
severe ileus, post GI surgery or biopsy, acute GI injury or burn,
or recent radiotherapy to pelvis - at high risk of aspiration such as those with prior aspiration,
tracheo-esophageal fistula, or obtundation - known severe hypersensitivity to barium sulfate or any of
the excipients of READI-CAT 2 or READI-CAT 2 SMOOTHIES
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available